Business

MedMira Announces Retirement of Board Chairman

HALIFAX, Jan. 5 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer ...

articleMedmira Inc.January 5, 20095/company/medmira-inc/news/medmira-announces-retirement-of-board-chairman
MedMira Announces Retirement of Board Chairman

About this update from Medmira Inc.

[{"type":"text","content":"\n\n\n\nHALIFAX, Jan. 5 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and\nsolutions, announced today that Stephen Sham is retiring as the Chairman of\nthe Board of Directors. Mr. Sham will step down as Chairman and will not seek\nre-election to the Board of Directors in the coming term.\n\n\n"I have decided that the time is right for me to retire," said Stephen\nSham. "I have completed my role here and I am leaving MedMira in good hands\nand wish the Company well in its future progress."\n\n\n"On behalf of everyone at the Company and our Board of Directors I want\nto thank Stephen for his contributions to MedMira. We are very appreciative of\nhis support and guidance through the years he served as both CEO and Chairman\nof the Board," said Hermes Chan, president and CEO, MedMira Inc. "Stephen's\ncontributions to MedMira in the past 15 years have played a key role in\nhelping us move forward from a start-up to become an internationally\nrecognized company in the diagnostics industry, and we wish him well in his\nretirement."\n\n\nThe Company expects to name a successor at its next board meeting after\nthe Annual General Meeting.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\ndiagnostics. The company's tests provide hospitals, labs, clinics and\nindividuals with reliable, rapid diagnosis for diseases such as HIV and\nhepatitis C in just three minutes. The company's tests are sold under the\nReveal(R), MiraWell(R), MiraCare(TM) and Multiplo(TM) brands in global\nmarkets. MedMira's rapid HIV test is the only one in the world to achieve\nregulatory approvals in Canada, the United States, China and the European\nUnion. MedMira's corporate offices and manufacturing facilities are located in\nHalifax, Nova Scotia, Canada. For more information visit MedMira's website at\nwww.medmira.com.\n\n\nThis news release contains forward-looking statements, which involve risk\nand uncertainties and reflect the company's current expectation regarding\nfuture events. Actual events could materially differ from those projected\nherein and depend on a number of factors including, but not limited to,\nchanging market conditions, successful and timely completion of clinical\nstud...

More updates from Medmira Inc.